You can buy or sell OpGen and other stocks, options, ETFs, and crypto commission-free!
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). Read More The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
— per share
Expected May 12, After Hours